This Article Full Text Full Text (PDF) All Versions of this Article: 135/4/527    most recent REP-07-0496v1 Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Shirasuna, K. Articles by Miyamoto, A. PubMed PubMed Citation Articles by Shirasuna, K. Articles by Miyamoto, A.

Prostaglandin F₂ increases endothelial nitric oxide synthase in the periphery of the bovine corpus luteum: the possible regulation of blood flow at an early stage of luteolysis

Graduate School of Animal and Food Hygiene, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan¹ Department of Animal Science, University of Peradeniya, Peradeniya 20400, Sri Lanka² Department of Obstetrics and Gynecology, Olson Center for Women's Health, University Nebraska Medical Center and Veterans Affairs Medical Center, Omaha, Nebraska 68198, USA, Departments of³ Clinical Veterinary Science⁴ Basic Veterinary Sciences, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan

Correspondence should be addressed to A Miyamoto; Email: akiomiya{at}obihiro.ac.jp

Prostaglandin F₂ (PGF₂) released from the uterus causes alterations in luteal blood flow, reduces progesterone secretion, and induces luteolysis in the bovine corpus luteum (CL). We have recently discovered that luteal blood flow in the periphery of the mature CL acutely increases coincidently with pulsatile increases in a metabolite of PGF₂ (PGFM). In this study, we characterized changes in regional luteal blood flow together with regional alterations in endothelial nitric oxide synthase (eNOS) expression during spontaneous luteolysis and in response to PGF₂. Smooth muscle actin-positive blood vessels larger than 20 µm were observed mainly in the periphery of mature CL. PGF₂ receptor was localized to luteal cells and large blood vessels in the periphery of mid-CL. PGF₂ acutely stimulated eNOS expression in the periphery but not in the center of mature CL. Injection of the NO donor S-nitroso-N-acetylpenicillamine into CL induced an acute increase in luteal blood flow and shortened the estrous cycle. In contrast, injection of the NOS inhibitor L-NAME into CL completely suppressed the acute increase in luteal blood flow induced by PGF₂ and delayed the onset of luteolysis. In conclusion, PGF₂ has a site-restricted action depending on not only luteal phase but also the region in the CL. PGF₂ stimulates eNOS expression, vasodilation of blood vessels, and increased luteal blood flow in periphery of mature CL. Furthermore, the increased blood flow is mediated by NO, suggesting that the acute increase in peripheral blood flow to CL is one of the first physiological indicators of NO action in response to PGF₂.